Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care

Presenter/Author Information

• Ramona Donovan MS, Advocate Aurora Research Institute, Advocate HealthFollow
• Rasha Khatib PhD, MHS, Advocate Aurora Research Institute, Advocate HealthFollow
• Christopher Blair MS, Takeda Pharmaceuticals U.S.A, Inc
• Maggie McCue, Takeda Pharmaceuticals U.S.A, Inc
• Ben Fehnert Cognition Kit, Cambridge, UK and Ctrl Group, Fora Health, London, UK
• James King, Ctrl Group/Fora Health, London, UK
• Michael Martin, Takeda Pharmaceuticals U.S.A., Inc
• Marybeth Ingle PhD, MPH, Advocate Aurora Research Institute, Advocate HealthFollow
• Iridian Guzman MPH, Advocate Aurora Research Institute, Advocate HealthFollow
• David Kemp MD, Behavioral Health, Advocate Christ Medical Center, Advocate HealthFollow

Recommended Citation

Donovan R, Khatib R, Blair C, et al. Implementation and Evaluation of the Pathway Platform: A Digitally Enabled Care Pathway to Improve Depression Management in Primary Care. J Patient Cent Res Rev. 2024;11:238-239. doi: 10.17294/2330-0698.2137

Affiliations

Advocate Aurora Research Institute, Advocate Christ Medical Center

Presentation Notes

Oral presentation at Scientific Day; May 22, 2024; Milwaukee, WI. https://institutionalrepository.aah.org/sciday/2024/oral1/6/

Document Type

Abstract